Endoscopy, 2009, issue 4

Editorial

Slovo úvodem

MUDr. Ing. Filip Závada

Endoskopie 2009; 18(4): 135  

Main topic

Chromoendoscopy

MUDr. Petr Fojtík, MUDr. Ondřej Urban Ph.D, MUDr. Martin Kliment, MUDr. Přemysl Falt, MUDr. David Janík, MUDr. Aleš Albín

Endoskopie 2009; 18(4): 139-143  

Diagnostics and treatment of the early neoplastic lesions attract attention of all endosopists nowadays. New technologies are developed and everyone strives for optimal technique of scanning large areas of the mucosa and searching for possible neoplastic lesions by means of highlighting suspected spots. Chromoendoscopy could be very helpful in this field. It is affordable, accessible and feasible. Many stains have been tried out through the years. However, only some of them proved to be usable in daily practice – Lugol´s solution, indigo carmine, Congo red, methylene blue and acetic acid. In spite of its similar effect the last-mentioned...

Endoscopic diagnostics and treatment of oesophagus early cancer

MUDr. Stanislav Rejchrt, MUDr. Rudolf Repák, prof. MUDr. Jan Bureš, CSc

Endoskopie 2009; 18(4): 144-149  

Barrett´s oesophagus (BE) is a well-known premalignant condition that can be associated with the developement of dysplasia and adenocarcinoma. Early diagnosis of neoplastic lesions arising in BE has become more frequent as a result of improved endoscopic technology, sureveillance programmes and increasing experience and awareness on the part of endoscopists. In the past, esophagectomy was the standard treatment for patients with BE with early cancer and high-grade dysplasia. In recent years endoscopic resection has become increasingly important, both as a diagnostic tool for staging and as a method of definitive treatment followed by ablation of residual...

Endoscopic diagnosis and treatment of superficial colorectal neoplasia

MUDr. Martin Kliment, MUDr. Přemysl Falt, MUDr. Petr Fojtík, MUDr. Ondřej Urban Ph.D

Endoskopie 2009; 18(4): 150-155  

Colorectal cancer (CRC) is the second most prevalent malignancy with good prognosis in case of early diagnosis and treatment. Approximately 70 % of CRCs develope through adenoma–carcinoma sequence, whereas 30 % probably develope without previous adenomatous precursors, de novo. Colonoscopy with techniques of endoscopic polypectomy and mucosal resection plays a major role in the secondary prevention of CRC by the interruption of adenoma–carcinoma sequence. Moreover, it is essential in the diagnosis and treatment of early CRC. In this paper the authors inform about endoscopic diagnosis and treatment of superficial colorectal neoplasia...

Endoscopic treatment of early stomach cancer: our own results from the years 2000-2009

MUDr. Ondřej Urban Ph.D, MUDr. Petr Fojtík, MUDr. Martin Kliment, MUDr. Petr Vítek, MUDr. Aleš Albín, MUDr. Přemysl Falt, MUDr. Josef Chalupa

Endoskopie 2009; 18(4): 156-160  

Aim: The aim of the paper is to present our own experience with endoscopic treatment of early stomach cancer. Patient cohort and method: Twenty-two consecutive patients treated in the years 2000–2009 are presented. Results: A total of 13 (59 %) patients underwent treatment with endoscopic mucosal resection or endoscopic submucosal dissection, out of whom three (14 %) were subsequently operated on electively. In a total of nine (41 %) patients, endoscopic treatment was considered to be curative. Seven (32 %) patients were indicated for primary surgical treatment, a total of ten (45 %) patients were eventually operated on. Two patients were...

Endoscopic diagnosis and treatment of early spinocellular carcinoma of the oesophagus is possible even in a population with low incidence of this disease

MUDr. Petr Vítek, doc. MUDr. Pavel Komínek Ph.D, MUDr. Ivana Kajzrlíková, MUDr. Josef Chalupa, MUDr. Jiří Kuchař, MUDr. Jiří Platoš, MUDr. Vladimír Hořava jr, MUDr. Pavel Řeha, MUDr. Petr Klečka

Endoskopie 2009; 18(4): 161-166  

The Czech Republic is among countries with a low incidence of spinocellular carcinoma of the oesophagus, a condition usually diagnosed at an advanced stage. Patients with head and neck tumours are at a higher risk for this disease. The authors present a group of 119 patients with head and neck tumours in whom a total of five synchronous and metachronous neoplastic lesions in oesophageal squamous epithelium were found using chromoendoscopy with Lugol‘s solution; a patient with severe dysplasia was then successfully treated with endoscopic resection. Chromoendoscopy of the oesophagus using Lugol‘s solution in risk groups of patients appears...

Review articles

Transurethral resection in the treatment of Ta T1 bladder tumors

prof. MUDr. Marko Babjuk, CSc

Endoskopie 2009; 18(4): 167-171  

Transurethral resection of bladder cancer (TURB) is the initial and critical step in the management of bladder tumors. The optimal outcomes can be achieved by systematically and meticulously performed procedure by well trained urologist. The TURB should be performed with modern equipment including new telescopes and video systems. Moreover, urologists should be aware of promising innovations including new imaging techniques (fluorescence cystoskopy or narrow band imaging) and their possible benefits. The risk of tumor persistence and understaging can be in selected cases reduced by re-TUR.

Video case reports

Primary neuroendocrine carcinoma of the urethra

MUDr. Andrea Kastnerová, MUDr. Oto Köhler CSc, MUDr. Kamil Belej Ph.D., FEBU, MUDr. Petr Hrabal, MUDr. Patrik Georgiev

Endoskopie 2009; 18(4): 172-174  

We demonstrate a case report of a patient with an uncommon finding of primary neuroendocrine carcinoma in the male urethra. Primary neuroendocrine tumor in this area is rare, there are only three cases described in the literature. We treated this case by endoscopic transurethral ablation with holmium laser.

What is your diagnosis?

Jaká je vaše diagnóza ?

Endoskopie 2009; 18(4): 181  


Endoscopy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.